Member Info for Junior1618

So you hold 27m shares but think this is on AIM?

Don't be late for school pal!

Hope you are not doing Maths GCSE in a few weeks TWK!

I find these results very uninspiring - no real sales progress and the dreaded caveat of the difficult NHS environment. New funds will be needed again before EBITDA positive. Gino needs to go and we need a CEX to drive forward sales - he is a Scientist not a CEX.

TWK - thats one of the dumbest posts you have ever authored. Anyway better hurry up, first lesson at school must be starting soon for you pal.

Nice to see a bit of that rise here today!

Https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=ENET.L

TWK - time for school pal.

Blueroad - with respect, I do know how these things work and thats exactly how they do work. Close ties to the GVT are very handy when you are looking for approvals etc!

MrH_m - why do you think approval from the Indonesian Gvt will take months? The Arsari Group owner is the younger brother of the Indonesian President!

Hopefully the catalyst for a strong week ahead!

You always know when a SP is about to surge - Roger65 arrives with some outrageous claims. Seen it so many times on other companies chat boards.

JCEP - the phrase 'very near term' in the Dec 22nd RNS referred to future strategic workstreams which turned out to be the Gloucestershire Police news two days later. They then said they hoped to release further details on Ixian in the 'near term' which is what I think you are talking about - the problem is that everyone (esp the markets) will have a different definition of what near term is - I personally think it is within q1, which someone else has pointed out is only half way through,

As a LTH, I am very grateful for DH but the fact is that it was deplorable that the company got itself in a situation where they had less than a months cash left. Despite recent limp protestations, the Chair has overseen a total value destruction of the company's SP and it is very unclear what value he or indeed the other NED's brings to the company. Russ is at most a competent financial controller and his robotic performances at the recent update confirmed to me he is not CFO material in any way. Many CEX's would have resigned a long time ago if they had overseen the shambles and humiliation of the recent non-equity financing so Gino is clinging on - he should be the CSO not CEX. We therefore need new fresh, progressive and commercial leadership!

A lot of this mess lies squarely with the Chair - what has his role been over the last few years? He's clearly a well connected individual in the life science world but what has he contributed other than overseeing a spectacular share price collapse. You would have thought he could have been the catalyst for other types of funding etc but nothing. He should consider his position and I will not be recommending at the AGM in Dec, he is re-elected.

Roger - I wouldnt rush investing today, I suspect the market wont like the desperate tone of this RNS.

This is a pathetic and humiliating RNS from the company - it accelerates my view for one around their duplicity and mismanagement of previous comms on funding. They are clearly out of their depth and now begging shareholders to support them despite the utter contempt they have held us in for years.

Our problem remains that the people that got us in this mess are still there. We have a Chair who has done nothing from what I can see, we have a CEO who is a talented Scientist but not a Chief Executive in terms of commercial / business experience and we have a CFO who cant communicate. I remain very upbeat about the company's tests and potential but I seriously questions whether we have the right leadership team in place.

Thanks GL - sounds positive but they are still saying they will need more funds next year and wont be EBITDA positive until mid 2027, suggesting to me that they are not confident of significant revenues for at least a year. The other issue I have is that the 'leaders' who got us in this mess are still in place and are they the right people to deliver long term growth and value for shareholders?

Last paragraph of - 3. Current trading and outlook post the Fundraising